CDC73 explained

Cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae), also known as CDC73 and parafibromin, is a protein which in humans is encoded by the CDC73 gene.[1] [2] [3]

Function

Parafibromin, LEO1, PAF1, and CTR9 form the PAF protein complex, which associates with the RNA polymerase II subunit POLR2A and with a histone methyltransferase complex.[4]

Clinical significance

Mutations in the CDC73 gene are associated with hyperparathyroidism-jaw tumor syndrome (HPT-JT)[3] and parathyroid carcinomas.[5] [6]

See also

External links

Further reading

Notes and References

  1. Web site: Entrez Gene: CDC73 Cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae).
  2. Sood R, Bonner TI, Makalowska I, Stephan DA, Robbins CM, Connors TD, Morgenbesser SD, Su K, Faruque MU, Pinkett H, Graham C, Baxevanis AD, Klinger KW, Landes GM, Trent JM, Carpten JD . Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus . Genomics . 73 . 2 . 211–22 . April 2001 . 11318611 . 10.1006/geno.2001.6500 .
  3. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Höög A, Heath H, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR . Rajesh Thakker . HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome . Nat. Genet. . 32 . 4 . 676–80 . December 2002 . 12434154 . 10.1038/ng1048 . 23713328 .
  4. Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, Resau JH, Meyerson M . The parafibromin tumor suppressor protein is part of a human Paf1 complex . Mol. Cell. Biol. . 25 . 2 . 612–20 . January 2005 . 15632063 . 543415 . 10.1128/MCB.25.2.612-620.2005 .
  5. Shattuck TM, Välimäki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A . Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma . N. Engl. J. Med. . 349 . 18 . 1722–9 . October 2003 . 14585940 . 10.1056/NEJMoa031237 . free .
  6. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT . HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours . J. Med. Genet. . 40 . 9 . 657–63 . September 2003 . 12960210 . 1735580 . 10.1136/jmg.40.9.657.